Cvs Health Stock Price Target

A few analysts raised the target prices on cvs stock.

Cvs health stock price target. The new note on the price target was released on september 27, 2019, representing the official price target for cvs health corporation stock. The average price target is $82.43, with a high forecast of $101.00 and a low forecast of $66.00. This is 2.47% more than the trading day before monday, 23rd nov 2020.

Piper sandler’s price target would suggest a potential upside of 7.73% from the stock’s previous close. Previously, the target price had yet another raise to $75, while credit suisse analysts kept a outperform rating on cvs stock. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.

Cvs's went public 34.95 years ago, making it older than 92.99% of listed us stocks we're tracking. On average, wall street analysts predict that cvs health corp's share price could reach $80.82 by sep 17, 2021. Deutsche bank aktiengesellschaft’s price target points to a potential upside of 55.50% from the company’s […]

Analyst ratings, historical stock prices, earnings estimates & actuals. Cvs has a higher average analyst price target than 83.64% of healthcare stocks. Analyst estimates, including cvs earnings per share estimates and analyst recommendations.

Net sales (including intragroup) break down by activity as follows: The high price target for cvs is $101.00 and the low price target for cvs is $66.00. Cvs) share prices have increased by 9.77% over the past week, but are up 23.67% over prices posted in the last quarter.

The company's pharmacy services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. The current projected cvs health target price consensus is 80.82 with 17 analyst opinions. Shares the of the drug store chain and health care services company are.